Vertex Pharmaceuticals shareholders have earned a 14 percent CAGR over the last five years - Yahoo Finance
VRTX34 Stock | BRL 619.20 14.62 2.42% |
About 55% of Vertex Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Vertex Pharmaceuticals Incorporated suggests that some traders are interested regarding Vertex Pharmaceuticals' prospects. The current market sentiment, together with Vertex Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Vertex Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Vertex |
Vertex Pharmaceuticals shareholders have earned a 14 percent CAGR over the last five years Yahoo Finance
Read at news.google.com
Vertex Pharmaceuticals Fundamental Analysis
We analyze Vertex Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vertex Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vertex Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Vertex Pharmaceuticals is rated fourth in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Vertex Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vertex Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Vertex Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Vertex Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Vertex Pharmaceuticals Related Equities
BIOM3 | Biomm SA | 6.74 | ||||
N1VO34 | Novo Nordisk | 6.39 | ||||
VRTX34 | Vertex Pharmaceuticals | 2.42 | ||||
T1CH34 | Bio Techne | 1.31 | ||||
B1NT34 | BIONTECH | 0.87 | ||||
M1RN34 | Moderna | 0.41 | ||||
A1SN34 | Ascendis Pharma | 0.00 | ||||
B1GN34 | BeiGene | 3.34 |
Complementary Tools for Vertex Stock analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |